ICU Medical, Inc. (ICUI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 530.37M | 540.31M | 536.99M | 548.87M | 604.7M | 629.8M | 589.13M | 596.46M | 566.65M | 587.86M | 553.31M | 549.31M |
| Revenue Growth % | -12.29% | -14.21% | -8.85% | -7.98% | 6.71% | 7.14% | 6.47% | 8.58% | -0.35% | 1.7% | -7.45% | -2.08% |
| Cost of Goods Sold | 357.28M | 338.18M | 336.11M | 340.8M | 394.59M | 402.55M | 384.28M | 389.03M | 381.41M | 416.27M | 369.39M | 356.98M |
| COGS % of Revenue | 67.36% | 62.59% | 62.59% | 62.09% | 65.25% | 63.92% | 65.23% | 65.22% | 67.31% | 70.81% | 66.76% | 64.99% |
| Gross Profit | 173.1M | 202.13M | 200.88M | 208.06M | 210.11M | 227.26M | 204.85M | 207.43M | 185.24M | 171.59M | 183.92M | 192.33M |
| Gross Margin % | 32.64% | 37.41% | 37.41% | 37.91% | 34.75% | 36.08% | 34.77% | 34.78% | 32.69% | 29.19% | 33.24% | 35.01% |
| Gross Profit Growth % | -17.62% | -11.06% | -1.94% | 0.31% | 13.42% | 32.45% | 11.38% | 7.85% | -3.54% | -1.92% | -1.33% | 14.76% |
| Operating Expenses | 142.42M | 176.9M | 187.16M | 197.48M | 197.22M | 189.57M | 196.62M | 199.74M | 195.9M | 183.77M | 161.07M | 189.57M |
| OpEx % of Revenue | 26.85% | 32.74% | 34.85% | 35.98% | 32.61% | 30.1% | 33.37% | 33.49% | 34.57% | 31.26% | 29.11% | 34.51% |
| Selling, General & Admin | 154.57M | 155.81M | 152.77M | 159.39M | 157.23M | 158.85M | 162.71M | 159.55M | 157.66M | 154.62M | 148.61M | 150.9M |
| SG&A % of Revenue | 29.14% | 28.84% | 28.45% | 29.04% | 26% | 25.22% | 27.62% | 26.75% | 27.82% | 26.3% | 26.86% | 27.47% |
| Research & Development | 21.28M | 21.09M | 21.25M | 21.87M | 23.29M | 22.36M | 21.03M | 23.39M | 21.84M | 22.41M | 20.87M | 22.3M |
| R&D % of Revenue | 4.01% | 3.9% | 3.96% | 3.98% | 3.85% | 3.55% | 3.57% | 3.92% | 3.85% | 3.81% | 3.77% | 4.06% |
| Other Operating Expenses | -1000K | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K |
| Operating Income | 30.68M | 25.23M | 13.72M | 10.59M | 12.89M | 37.69M | 8.24M | 7.69M | -10.65M | -12.18M | 22.85M | 2.76M |
| Operating Margin % | 5.78% | 4.67% | 2.55% | 1.93% | 2.13% | 5.98% | 1.4% | 1.29% | -1.88% | -2.07% | 4.13% | 0.5% |
| Operating Income Growth % | 138.04% | -33.06% | 66.57% | 37.64% | 220.96% | 409.37% | -63.96% | 178.7% | -213.41% | -5387.84% | 4993.58% | 5850% |
| EBITDA | 80.7M | 79.57M | 64.52M | 60.25M | 62.33M | 90.7M | 63.84M | 63.01M | 44.87M | 44.98M | 296.6M | 60.26M |
| EBITDA Margin % | 15.22% | 14.73% | 12.02% | 10.98% | 10.31% | 14.4% | 10.84% | 10.56% | 7.92% | 7.65% | 53.6% | 10.97% |
| EBITDA Growth % | 29.47% | -12.27% | 1.07% | -4.38% | 38.92% | 101.67% | -78.48% | 4.56% | -31.07% | -20.52% | 409.85% | -9.4% |
| D&A (Non-Cash Add-back) | 50.03M | 54.34M | 50.8M | 49.66M | 49.45M | 53.01M | 55.6M | 55.32M | 55.53M | 57.16M | 273.75M | 57.5M |
| EBIT | 30.68M | 6.45M | 15.75M | 56.74M | 14.36M | 34.41M | 9.36M | 7.12M | -10.35M | -9.97M | 11.74M | 2.97M |
| Net Interest Income | 16.49M | -22.7M | -19.81M | -20.55M | -25.79M | -23.46M | -24.68M | -23.84M | -23.77M | -24.41M | -24.18M | -24.12M |
| Interest Income | 0 | 2.14M | 0 | 2.52M | 3.23M | 2.73M | 2.6M | 2.81M | 2.65M | 2.3M | 1.75M | 1.71M |
| Interest Expense | -16.49M | 24.84M | 19.81M | 23.07M | 29.02M | 26.19M | 27.29M | 26.65M | 26.42M | 26.71M | 25.92M | 25.83M |
| Other Income/Expense | -35.26M | -43.62M | -17.77M | 25.93M | -23.79M | -29.47M | -26.16M | -27.23M | -26.11M | -24.5M | -28.22M | -25.62M |
| Pretax Income | -4.58M | -18.39M | -4.05M | 36.52M | -10.91M | 8.22M | -17.93M | -19.53M | -36.77M | -36.68M | -5.37M | -22.86M |
| Pretax Margin % | -0.86% | -3.4% | -0.75% | 6.65% | -1.8% | 1.3% | -3.04% | -3.27% | -6.49% | -6.24% | -0.97% | -4.16% |
| Income Tax | -34.71M | -2.65M | -658K | 1.18M | 4.57M | 32.05M | 15.05M | 1.87M | 2.7M | -19.53M | -12.6M | -12.93M |
| Effective Tax Rate % | 757.62% | 14.43% | 16.23% | 3.23% | -41.9% | 389.98% | -83.97% | -9.59% | -7.35% | 53.25% | 234.89% | 56.55% |
| Net Income | 30.13M | -15.73M | -3.4M | 35.34M | -15.48M | -23.83M | -32.98M | -21.41M | -39.47M | -17.15M | 7.24M | -9.93M |
| Net Margin % | 5.68% | -2.91% | -0.63% | 6.44% | -2.56% | -3.78% | -5.6% | -3.59% | -6.97% | -2.92% | 1.31% | -1.81% |
| Net Income Growth % | 294.7% | 33.97% | 89.7% | 265.08% | 60.79% | -38.96% | -555.69% | -115.48% | -302.27% | -10.37% | 154.8% | -32.91% |
| Net Income (Continuing) | 30.13M | -15.73M | -3.4M | 35.34M | -15.48M | -23.83M | -32.98M | -21.41M | -39.47M | -17.15M | 7.24M | -9.93M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 1.20 | -0.64 | -0.14 | 1.43 | -0.63 | -0.97 | -1.35 | -0.88 | -1.63 | -0.71 | 0.30 | -0.41 |
| EPS Growth % | 290.48% | 34.02% | 89.63% | 262.5% | 61.35% | -36.62% | -550% | -114.63% | -297.56% | -9.23% | 154.55% | -32.26% |
| EPS (Basic) | 1.22 | -0.64 | -0.14 | 1.43 | -0.63 | -0.97 | -1.35 | -0.88 | -1.63 | -0.71 | 0.30 | -0.41 |
| Diluted Shares Outstanding | 25.18M | 24.69M | 24.69M | 24.71M | 24.54M | 24.49M | 24.44M | 24.39M | 24.22M | 24.14M | 24.37M | 24.07M |
| Basic Shares Outstanding | 24.76M | 24.69M | 24.69M | 24.64M | 24.54M | 24.49M | 24.44M | 24.39M | 24.22M | 24.14M | 24.13M | 24.07M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |